Metraipolis › archive › dc_8a50e91e6283
TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases — Europe PMC PMID:40869160
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40869160
- DOI
- 10.3390/ijms26167839
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T15:22:08.793Z
- SHA-256 of the archived text
9dc2169bf06f13c4666532023a5e1da5eb2b22cd34239c3240f9a087b4c2aec2- Stable URL of this page
https://metraipolis.com/documento/dc_8a50e91e6283
How to cite
TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases — Europe PMC PMID:40869160 — Europe PMC (en), https://europepmc.org/article/MED/40869160 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a50e91e6283 (Metraipolis archive dc_8a50e91e6283, sha256 9dc2169bf06f13c4666532023a5e1da5eb2b22cd34239c3240f9a087b4c2aec2)
BibTeX
@misc{dc8a50e91e6283,
title = {TNFR2 Agonism: Basic Science and Promising Treatment for Multiple Sclerosis and Related Diseases — Europe PMC PMID:40869160},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40869160},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a50e91e6283; sha256 9dc2169bf06f13c4666532023a5e1da5eb2b22cd34239c3240f9a087b4c2aec2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869160. Agents can read the archived copy with the MCP tool read_document.